About Us

Our People

DAVA Oncology

At DAVA Oncology, we are dedicated to the facilitation of clinical research and development of new and existing cancer therapeutics. In order to better perform this goal, DAVA utilizes a staff of oncology experts to provide medical oncology support and knowledge-based strategic insight. Our people are led by five seasoned medical oncologists with decades of clinical oncology experience, two PhDs with extensive training in oncology and two pharmaceutically-trained executives with many years of experience in the oncology space.

Executive Management

Mark Levonyak
President

  • Broad pharmaceutical industry experience, including new product planning and commercialization

  • Launched three oncology products (Kytril, Hycamtin, Trisenox)

  • Instrumental in new product planning for four oncology products (Xyotax, Xyocam, Pixantrone, Mozobil)

  • Developed and led 3 oncology sales and marketing teams (SmithKline Beecham, Cell Therapeutics, AnorMED)

John Eckardt, MD
Chief Medical Officer

  • Board certified Medical Oncologist

  • Trained in Oncology Drug Development under Dr. Dan Von Hoff in San Antonio, Texas

  • Private practice medical oncologist since 1993

  • Developed community-based clinical research program for Phase I, II, and III clinical trials

Active clinical speaker for lung cancer, breast cancer and new drug development

Martin Lee, MD
Executive VP of Clinical Trial Services

  • Board certified in Internal Medicine and Medical Oncology

  • Experienced in private and group medical oncology practice, 1987-2006

  • IRB chair in academic and community settings, 1990-2006

  • Medical Director, Oncology Research, in a large multispecialty healthcare system, 1996-2006

  • Medical Director, Global Drug Development (Oncology), PPD, Inc., 2006-2008

  • Executive Director/Vice President, Site and Patient Recruitment, PPD, Inc., 2008-2011

  • Recognized industry expert in clinical trial feasibility and patient recruitment

Nora Ku, MD
Senior Medical Director

  • Board Certified in Medical Oncology, Hematology and Internal Medicine

  • Academic faculty at UC Irvine (1992-1995) and University of Miami (2007-2008)

  • Private Practice Hematology/Medical Oncology 1996-2007

  • Member of TORI/UCLA network 1996-2007, a community/academic research network

Annemieke DeMaggio, PhD
VP of Scientific Affairs

  • Extensive oncology research training

  • Broad pharmaceutical industry experience: Medical & Clinical Affairs, Marketing

  • Strategic consulting expertise and portfolio planning

  • Skilled in medical and scientific communications

Nicolas Kuehl
VP of Business Development, Client Services

  • Extensive professional oncology experience

  • Broad commercial marketing, strategic planning and asset management

  • Alliance management

Gregory Pynes, MPA
Executive Director, Meetings, Branding, and Partnerships

  • Extensive professional oncology experience in CME and On Label Meeting Management

  • Senior Director of Meetings and Partnerships, Physicians’ Education Resource, 2001-2011

  • Brand Management

  • Academic and Practice Partnership development